N-(4-aminobutyl)-4-[(3R,5R,7S,8R,14S)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanamide;butane-1,4-diamine;deuterio(fluoro)methane;methane;4-[(3R,5R,7S,8R,14S)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid

C58H109FN4O9 — CID 157269374

IUPACN-(4-aminobutyl)-4-[(3R,5R,7S,8R,14S)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanamide;butane-1,4-diamine;deuterio(fluoro)methane;methane;4-[(3R,5R,7S,8R,14S)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid
SMILESC.CC(CCC(=O)NCCCCN)C1CC[C@H]2[C@H]3C(CC(O)C12C)C1(C)CC[C@@H](O)C[C@@H]1C[C@@H]3O.CC(CCC(=O)O)C1CC[C@H]2[C@H]3C(CC(O)C12C)C1(C)CC[C@@H](O)C[C@@H]1C[C@@H]3O.NCCCCN.[2H]CF
InChIInChI=1S/C28H50N2O4.C24H40O5.C4H12N2.CH3F.CH4/c1-17(6-9-25(34)30-13-5-4-12-29)20-7-8-21-26-22(16-24(33)28(20,21)3)27(2)11-10-19(31)14-18(27)15-23(26)32;1-13(4-7-21(28)29)16-5-6-17-22-18(12-20(27)24(16,17)3)23(2)9-8-15(25)10-14(23)11-19(22)26;5-3-1-2-4-6;1-2;/h17-24,26,31-33H,4-16,29H2,1-3H3,(H,30,34);13-20,22,25-27H,4-12H2,1-3H3,(H,28,29);1-6H2;1H3;1H4/t17?,18-,19-,20?,21+,22?,23+,24?,26+,27?,28?;13?,14-,15-,16?,17+,18?,19+,20?,22+,23?,24?;;;/m11.../s1/i;;;1D;
InChIKeyAYIZPJZVTSDSDF-DNXCEYJPSA-N
MW1026.53 g/mol
LogP7.57
Rot. Bonds15

About N-(4-aminobutyl)-4-[(3R,5R,7S,8R,14S)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanamide;butane-1,4-diamine;deuterio(fluoro)methane;methane;4-[(3R,5R,7S,8R,14S)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid

N-(4-aminobutyl)-4-[(3R,5R,7S,8R,14S)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanamide;butane-1,4-diamine;deuterio(fluoro)methane;methane;4-[(3R,5R,7S,8R,14S)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid (PubChem CID 157269374) has the molecular formula C58H109FN4O9 and a molecular weight of 1026.53 g/mol. Its IUPAC name is N-(4-aminobutyl)-4-[(3R,5R,7S,8R,14S)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanamide;butane-1,4-diamine;deuterio(fluoro)methane;methane;4-[(3R,5R,7S,8R,14S)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid.

Molecular Properties

Compound NameN-(4-aminobutyl)-4-[(3R,5R,7S,8R,14S)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanamide;butane-1,4-diamine;deuterio(fluoro)methane;methane;4-[(3R,5R,7S,8R,14S)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid
PubChem CID157269374
Molecular FormulaC58H109FN4O9
Molecular Weight1026.53 g/mol
Exact Mass1025.82
IUPAC NameN-(4-aminobutyl)-4-[(3R,5R,7S,8R,14S)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanamide;butane-1,4-diamine;deuterio(fluoro)methane;methane;4-[(3R,5R,7S,8R,14S)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid
SMILESC.CC(CCC(=O)NCCCCN)C1CC[C@H]2[C@H]3C(CC(O)C12C)C1(C)CC[C@@H](O)C[C@@H]1C[C@@H]3O.CC(CCC(=O)O)C1CC[C@H]2[C@H]3C(CC(O)C12C)C1(C)CC[C@@H](O)C[C@@H]1C[C@@H]3O.NCCCCN.[2H]CF
InChIInChI=1S/C28H50N2O4.C24H40O5.C4H12N2.CH3F.CH4/c1-17(6-9-25(34)30-13-5-4-12-29)20-7-8-21-26-22(16-24(33)28(20,21)3)27(2)11-10-19(31)14-18(27)15-23(26)32;1-13(4-7-21(28)29)16-5-6-17-22-18(12-20(27)24(16,17)3)23(2)9-8-15(25)10-14(23)11-19(22)26;5-3-1-2-4-6;1-2;/h17-24,26,31-33H,4-16,29H2,1-3H3,(H,30,34);13-20,22,25-27H,4-12H2,1-3H3,(H,28,29);1-6H2;1H3;1H4/t17?,18-,19-,20?,21+,22?,23+,24?,26+,27?,28?;13?,14-,15-,16?,17+,18?,19+,20?,22+,23?,24?;;;/m11.../s1/i;;;1D;
InChIKeyAYIZPJZVTSDSDF-DNXCEYJPSA-N
XLogP7.57
TPSA265.84 Ų
H-Bond Donors11
H-Bond Acceptors11
Rotatable Bonds15
Heavy Atoms72
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001026.53
LogP ≤ 57.57
H-Bond Donors ≤ 511
H-Bond Acceptors ≤ 1011

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze N-(4-aminobutyl)-4-[(3R,5R,7S,8R,14S)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanamide;butane-1,4-diamine;deuterio(fluoro)methane;methane;4-[(3R,5R,7S,8R,14S)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-(4-aminobutyl)-4-[(3R,5R,7S,8R,14S)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanamide;butane-1,4-diamine;deuterio(fluoro)methane;methane;4-[(3R,5R,7S,8R,14S)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid?
The IUPAC name of N-(4-aminobutyl)-4-[(3R,5R,7S,8R,14S)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanamide;butane-1,4-diamine;deuterio(fluoro)methane;methane;4-[(3R,5R,7S,8R,14S)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid (CID 157269374) is N-(4-aminobutyl)-4-[(3R,5R,7S,8R,14S)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanamide;butane-1,4-diamine;deuterio(fluoro)methane;methane;4-[(3R,5R,7S,8R,14S)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid.
What is the SMILES notation for N-(4-aminobutyl)-4-[(3R,5R,7S,8R,14S)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanamide;butane-1,4-diamine;deuterio(fluoro)methane;methane;4-[(3R,5R,7S,8R,14S)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid?
The canonical SMILES for N-(4-aminobutyl)-4-[(3R,5R,7S,8R,14S)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanamide;butane-1,4-diamine;deuterio(fluoro)methane;methane;4-[(3R,5R,7S,8R,14S)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid is C.CC(CCC(=O)NCCCCN)C1CC[C@H]2[C@H]3C(CC(O)C12C)C1(C)CC[C@@H](O)C[C@@H]1C[C@@H]3O.CC(CCC(=O)O)C1CC[C@H]2[C@H]3C(CC(O)C12C)C1(C)CC[C@@H](O)C[C@@H]1C[C@@H]3O.NCCCCN.[2H]CF.
What is the InChIKey of N-(4-aminobutyl)-4-[(3R,5R,7S,8R,14S)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanamide;butane-1,4-diamine;deuterio(fluoro)methane;methane;4-[(3R,5R,7S,8R,14S)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid?
The InChIKey is AYIZPJZVTSDSDF-DNXCEYJPSA-N. The full InChI is InChI=1S/C28H50N2O4.C24H40O5.C4H12N2.CH3F.CH4/c1-17(6-9-25(34)30-13-5-4-12-29)20-7-8-21-26-22(16-24(33)28(20,21)3)27(2)11-10-19(31)14-18(27)15-23(26)32;1-13(4-7-21(28)29)16-5-6-17-22-18(12-20(27)24(16,17)3)23(2)9-8-15(25)10-14(23)11-19(22)26;5-3-1-2-4-6;1-2;/h17-24,26,31-33H,4-16,29H2,1-3H3,(H,30,34);13-20,22,25-27H,4-12H2,1-3H3,(H,28,29);1-6H2;1H3;1H4/t17?,18-,19-,20?,21+,22?,23+,24?,26+,27?,28?;13?,14-,15-,16?,17+,18?,19+,20?,22+,23?,24?;;;/m11.../s1/i;;;1D;.
What are the key properties of N-(4-aminobutyl)-4-[(3R,5R,7S,8R,14S)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanamide;butane-1,4-diamine;deuterio(fluoro)methane;methane;4-[(3R,5R,7S,8R,14S)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid?
N-(4-aminobutyl)-4-[(3R,5R,7S,8R,14S)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanamide;butane-1,4-diamine;deuterio(fluoro)methane;methane;4-[(3R,5R,7S,8R,14S)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid has a molecular weight of 1026.53 g/mol, XLogP of 7.57, 15 rotatable bonds, 11 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for N-(4-aminobutyl)-4-[(3R,5R,7S,8R,14S)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanamide;butane-1,4-diamine;deuterio(fluoro)methane;methane;4-[(3R,5R,7S,8R,14S)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid is sourced from PubChem (CID 157269374), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).